Our Team
Jonathan Irwin
Chief Executive Officer
JD, LLM, MBA
Jonathan Irwin is CEO of AmebaGone. He has a background in biotechnology and extensive experience at the executive level in multiple startups..
Nathan Chesmore
Chief Scientific Officer
Ph.D.
Dr. Chesmore received his Ph.D. at the University of Wisconsin-Madison in the Department of Animal Sciences. His doctoral dissertation was the first to reveal the anti-biofilm strategy of Dicty and focused on the fractionation of Dicty compounds produced during their predation on bacteria.
Courtney Griese
Vice President
B.S.
Courtney Griese joined Amebagone in 2017. She holds a B.S. in Microbiology from the University of Wisconsin-Madison.
Scientific Advisors
Michael Bentz
Scientific Advisor
MD
Vice Chairman of Clinical Affairs, Dept. of Surgery, Chair, Division of Plastic and Reconstructive Surgery, University of Wisconsin-Madison School of Medicine and Public Health
Curtis Brant
Scientific Advisor
Ph.D.
Professor of Ophthalmology and Visual Sciences, Medical Microbiology and Immunology and the Clinical Cancer Center, University of Wisconsin-Madison School of Ophthalmology
Richard Proctor
Scientific Advisor
Ph.D.
Professor Emeritus, Department of Medicine and Microbiology, University of Wisconsin-Madison. Retired Global Director for Infectious Diseases for Antibiotics and Antifungals, Merck
John C. Landolt
Scientific Advisor
Ph.D.
Professor Emeritus, Plant Biology, Shepherd University, West Virginia
Advisory Team
David Casimir
Legal Advisor
JD, Ph.D.
Shareholder, Casimir and Jones
Founder
Marcin Filutowicz
Founder
Ph.D.
Marcin Filutowicz (1950–2022) founded AmebaGone in 2010 with the goal of commercializing the use of amoebae for biocontrol and disease treatment.